Biocompatible phase invertible proteinaceous compositions and methods for making and using the same

US10722610B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10722610-B2
Application numberUS-201916421035-A
CountryUS
Kind codeB2
Filing dateMay 23, 2019
Priority dateApr 17, 2009
Publication dateJul 28, 2020
Grant dateJul 28, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a crosslinker and a proteinaceous substrate. The proteinaceous substrate includes one or more proteins and a polyamine, where the polyamine and a proteinaceous substrate are present in synergistic viscosity enhancing amounts, and may also include one or more of: a carbohydrate, a tackifying agent, a plasticizer, or other modification agent. In certain embodiments, the crosslinker is a heat-treated dialdehyde, e.g., heat-treated glutaraldehyde. Also provided are kits for use in preparing the subject compositions. The subject compositions, kits and systems find use in a variety of different applications.

First claim

Opening claim text (preview).

What is claimed is: 1. A phase invertible composition produced by combining: a substrate comprising a polyamine and a proteinaceous material in a weight ratio of polyamine to proteinaceous material being in the range from 1:10 to 1:40, wherein the combination of the polyamine and the proteinaceous material has a viscosity which is greater than that of either the polyamine or the proteinaceous material alone; and a crosslinking agent, wherein the crosslinking agent causes the polyamine and the proteinaceous material to crosslink and the polyamine and the proteinaceous material crosslink in the presence of the crosslinking agent, wherein the crosslinking agent is exposed to radiation, wherein the substrate has a kinematic viscosity of about 70 to 200 centistokes, wherein the proteinaceous material is selected from the group consisting of albumin, elastin, fibrin and soluble and insoluble forms of collagen and combinations thereof, and wherein the crosslinking agent comprises a macromolecular crosslinking agent comprising a reaction product of an excess of a liquid aldehyde cross linking agent and a glycosaminoglycan. 2. A kit for producing a phase invertible composition, the kit comprising: a substrate comprising a polyamine and a proteinaceous material in a weight ratio which produces a synergistic viscosity enhancing effect when combined, the weight ratio of polyamine to proteinaceous material being in the range from 1:10 to 1:40, wherein the combination of the polyamine and the proteinaceous material has a viscosity which is greater than that of either the polyamine or the proteinaceous material alone; and a crosslinking agent composition comprising a crosslinking agent, wherein the crosslinking agent causes the polyamine and the proteinaceous material to crosslink and the polyamine and the proteinaceous material crosslink in the presence of the crosslinking agent, wherein the crosslinking agent is exposed to radiation, wherein the substrate has a kinematic viscosity of about 70 to 200 centistokes, wherein the proteinaceous material is selected from the group consisting of albumin, elastin, fibrin and soluble and insoluble forms of collagen and combinations thereof and wherein the crosslinking agent comprises a macromolecular crosslinking agent comprising a reaction product of an excess of a liquid aldehyde cross linking agent and a glycosaminoglycan. 3. The kit of claim 2 , wherein the kit further comprises a phase invertible fluid delivery device. 4. The kit of claim 2 , wherein the radiation sterilizes the crosslinking agent. 5. The kit of claim 2 , wherein the radiation comprises gamma radiation. 6. The kit of claim 2 , wherein the radiation comprises electron beam radiation. 7. The kit of claim 2 , wherein the polyamine is a polyalkyleneimine. 8. The kit of claim 7 , wherein the polyalkyleneimine is a polyethyleneimine. 9. The kit of claim 8 , wherein the polyethyleneimine is a branched polyethyleneimine. 10. The kit of claim 2 , wherein the substrate further comprises a carbohydrate. 11. The kit of claim 10 , wherein the carbohydrate is chitosan. 12. The kit of claim 2 , wherein the crosslinking agent comprises an aldehyde. 13. The kit of claim 12 , wherein the aldehyde is glutaraldehyde. 14. The kit of claim 13 , wherein the glutaraldehyde is heat stabilized. 15. The kit of claim 2 , wherein the glycosaminoglycan is hyaluronan. 16. The kit of claim 2 , wherein the viscosity of the substrate approximates that of the crosslinking agent. 17. The kit of claim 16 , wherein the crosslinking agent further comprises a viscosity modifying agent. 18. The kit of claim 2 , wherein the substrate further comprises an agent selected from the group consisting of a tackifying agent, and a plasticizing agent. 19. The kit of claim 2 , wherein the crosslinking agent further comprises an agent selected from the group consisting of a tackifying agent, and a plasticizing agent. 20. The kit of claim 2 , wherein the polyamine comprises branched polyethyleneimine, the proteinaceous material comprises about 30% to about 50% albumin, the substrate further comprises about 0.1% to about 0.3% chitosan, and the liquid aldehyde cross linking agent comprises about 3% to about 10% heat-treated glutaraldehyde. 21. The kit of claim 2 , wherein the polyamine comprises about 1 to about 4% (w/w) branched polyethyleneimine, the proteinaceous material comprises about 40% albumin, the substrate further comprises about 0.16% chitosan, and the liquid aldehyde cross linking agent comprises about 4.4% to about 7.5% heat-treated glutaraldehyde.

Assignees

Inventors

Classifications

  • C08L79/02Primary

    Polyamines · CPC title

  • Compositions of proteins; Compositions of derivatives thereof (foodstuff preparations A23J3/00) · CPC title

  • Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof · CPC title

  • Hydrogels or hydrocolloids · CPC title

  • Plasticising macromolecular compounds (plasticisers C08K) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10722610B2 cover?
Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a crosslinker and a proteinaceous substrate. The proteinaceous substrate includes one or more proteins and a polyamine, where the polyamine and a proteinaceous substrate are present in synergistic viscosity enhancin…
Who is the assignee on this patent?
Baxter Int
What technology area does this patent fall under?
Primary CPC classification C08L79/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).